HOME >> MEDICINE >> NEWS
Cholesterol-lowering drugs reduce risk of stroke, heart attack

BOSTON -- People whose cholesterol improved after one month on cholesterol-lowering drugs called statins reduced their risk of stroke and heart attack, according to research that will be presented at the American Academy of Neurologys 59th Annual Meeting in Boston, April 28 May 5, 2007.

The study enrolled 4,731 people within one to six months of having a stroke or transient ischemic attack, or mini-stroke, and with no history of heart disease. Half of the participants received the cholesterol-lowering drug atorvastatin and half received a placebo. The participants were then followed for an average of four and a half years.

For each 10-percent decrease in LDL, or low-density lipoprotein bad cholesterol, the risk of stroke was reduced by four percent and the risk of heart attack was reduced by seven percent. The average decrease in LDL cholesterol after one month on atorvastatin was 53 percent.

These findings reinforce the importance of controlling cholesterol, said study author Pierre Amarenco, MD, of Denis Diderot University in Paris, France, and Fellow member of the American Academy of Neurology. Its encouraging to see that reducing cholesterol so quickly can have positive long-term effects.

People with higher levels of HDL, or high-density lipoprotein good cholesterol, at the beginning of the study and after one month had a lower risk of stroke.


'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
2-May-2007


Page: 1

Related medicine news :

1. Cholesterol-lowering drugs may be useful in an influenza pandemic
2. Cholesterol-lowering drugs not associated with increased breast cancer risk
3. UIC researchers to develop new drugs to fight bioterrorism
4. Statin drugs may delay progressive artery damage in children
5. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
6. Experts call for urgent research into anti-epileptic drugs given to children
7. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
8. Antipsychotic drugs increase risk of death in older people with dementia
9. Antipsychotic drugs increase risk of death in older people with dementia
10. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
11. Panel offers guidelines on skin reactions to new class of cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... , ... May 26, 2016 , ... ... discovery of thousands of defective respirators, according to court documents and SEC filings. ... of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... ... 26, 2016 , ... MadgeTech will be showcasing its line of data ... Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries around ... including NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the widest ... and those who do not use the app. Dr. Mohebi, the founder of Parsa Mohebi ... Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat videos ...
(Date:5/26/2016)... ... 26, 2016 , ... The Lung Institute has partnered with the ... starting June 6 at their clinic in downtown Tampa. The class is complimentary for ... Institute has created a free downloadable 4 Week Smoking Cessation Guide for ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... -- The healthcare sector is large and ... falling under its umbrella.  A rather overlooked sector are ... about, these healthcare companies are still trying to prove ... by far the largest consumer of the healthcare market ... Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics ...
(Date:5/26/2016)... A key trend that will ... of new treatments. Cardax, a development stage life sciences ... therapy is expected to fulfil large unmet medical needs ... studies to develop new treatments for osteoarthritis. One such ... in osteoarthritis are being investigated, and early trials of ...
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
Breaking Medicine Technology:
Cached News: